The two most commonly recognized types of sleep apnea are obstructive and central sleep ... cycles of reduced or stopped breathing (hypopnea) and increased breathing (hyperpnea).

More information: Vanessa Cavalcante-Silva et al, Homocysteine as a predictor of apnea–hypopnea index in obstructive sleep apnea: a longitudinal epidemiological study (EPISONO), European ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Study reveals that sleep traits predict over 15% of body characteristics across 15 physiological systems, with visceral fat, ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea ... index (BMI) and apnea-hypopnea index (AHI) values ...

Obstructive Sleep Apnea (OSA): A sleep disorder characterized by repeated interruptions in breathing during sleep due to the blockage of the upper airway. Apnea-Hypopnea Index (AHI): A measure ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said ... was the change in the apnea hypopnea index (AHI), which tracks how ...

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and Drug Administration approval last month.

Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for mo ...